Where is DP Bio located?

DP Bio is headquartered in Shenzhen, China.

Is DP Bio a funded company?

DP Bio is a funded company, having raised a total of $***** in its 1st and only funding round.

Where does DP Bio rank among its competitors?

DP Bio ranks 9th amongst 10 active competitors, of which 2 are funded. It stands 9th in terms of total funding among its competitors. The most recent competitor to raise funding was Huixin Biotech, which secured $14.4M in Feb, 2026.

Who are the top competitors of DP Bio?

DP Bio's top competitors include Purigen Biosystems, Diffinity Genomics and Huixin Biotech. Among them, Huixin Biotech secured the most recent funding round in February, 2026.

DP Bio - 2026 Company Profile & Competitors

Company Details

Developer of microdroplet technology for antibody analysis. The company provides high-performance analytical detection systems, accelerates and improves drug discovery and basic life science research.

Key Metrics

Founded Year

2018

Location

Shenzhen, China

Stage

Unfunded

Ranked

9^th among 10 active competitors

Similar Companies

Purigen Biosystems & 10 more

View DP Bio's full profile

DP Bio has not raised any funding rounds yet.

Access Tracxn on any website

Our Google Chrome extension lets you view company details while browsing their websites

Install Tracxn Extension

Top competitors of DP Bio include Purigen Biosystems, Diffinity Genomics and Huixin Biotech. Here is the list of Top 10 competitors of DP Bio, ranked by Tracxn score:

Rank	Company Details	Short Description	Total Funding	Investors	Tracxn Score
1st	Purigen Biosystems 2012, Pleasanton (United States), Acquired	Provider of isotachophoresis technology for nucleic acid sample preparation	$88.3M	Roche, Agilent & 4 others	48/100
2nd	Diffinity Genomics 2005, West Henrietta (United States), Acquired	-	$1.36M	Mass Medical Angels, Excell Partners & 2 others	37/100
3rd	Huixin Biotech 2021, Longhua (China), Series A	Developer of exosome purification products and early cancer detection technology	$28.1M	Legend Capital	30/100
4th	Wuxi Cuichun Biomaterials Technology 2022, China, Seed	Developer of purification processes and materials for cell gene therapy	-	CDH	30/100
5th	AccuBioMed 2012, Taipei (Taiwan), Unfunded	Developing automated nucleic acid purification systems	-	-	25/100
6th	nexttec 2013, Dachau (Germany), Unfunded	Provider of DNA purification system	-	-	24/100
7th	Nugen 2001, Westmont (United States), Early Stage	Developer of amplification and sample preparation systems for biological analysis	$25.5M	Hercules Capital	23/100
8th	Easy Life Science 2009, Paris (France), Unfunded	Developer of electrochemical DNA detection instruments for molecular biology	-	-	18/100
9th	DP Bio 2018, Shenzhen (China), Unfunded	Developer of microdroplet technology for antibody analysis	-	-	16/100
10th	Imessa Research 2011, Salt Lake City (United States), Unfunded	Developer of nanoparticle separation and characterization technology	-	-	16/100